CY1935A - Novel vaccine and method therefor - Google Patents

Novel vaccine and method therefor

Info

Publication number
CY1935A
CY1935A CY193591A CY193591A CY1935A CY 1935 A CY1935 A CY 1935A CY 193591 A CY193591 A CY 193591A CY 193591 A CY193591 A CY 193591A CY 1935 A CY1935 A CY 1935A
Authority
CY
Cyprus
Prior art keywords
method therefor
novel vaccine
detoxified
pertussis toxin
vaccine
Prior art date
Application number
CY193591A
Other languages
English (en)
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of CY1935A publication Critical patent/CY1935A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
CY193591A 1990-02-12 1991-02-07 Novel vaccine and method therefor CY1935A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12
PCT/EP1991/000257 WO1991012020A1 (en) 1990-02-12 1991-02-07 Novel vaccine and method therefor

Publications (1)

Publication Number Publication Date
CY1935A true CY1935A (en) 1991-02-07

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
CY193591A CY1935A (en) 1990-02-12 1991-02-07 Novel vaccine and method therefor

Country Status (16)

Country Link
EP (1) EP0515415B1 (de)
JP (1) JP3035712B2 (de)
KR (1) KR100202052B1 (de)
AT (1) ATE129159T1 (de)
AU (1) AU646019B2 (de)
CA (1) CA2075711C (de)
CY (1) CY1935A (de)
DE (1) DE69113991T2 (de)
DK (1) DK0515415T3 (de)
ES (1) ES2080941T3 (de)
GR (1) GR3018440T3 (de)
IE (1) IE70672B1 (de)
NZ (1) NZ237069A (de)
PT (1) PT96723B (de)
WO (1) WO1991012020A1 (de)
ZA (1) ZA91947B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3626996B2 (ja) 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
CA2341352C (en) * 1998-09-01 2013-01-08 Elan Corporation Plc Oral vaccine compositions
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
WO2013113729A1 (en) 2012-02-01 2013-08-08 Glaxosmithkline Biologicals S.A. Fermentation process
SG11201500573RA (en) 2012-08-06 2015-02-27 Glaxosmithkline Biolog Sa Method for eliciting in infants an immune response against rsv and b. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
SG11201600709TA (en) 2013-08-05 2016-02-26 Glaxosmithkline Biolog Sa Combination immunogenic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
AU5027890A (en) * 1989-02-10 1990-09-05 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
IE70672B1 (en) 1996-12-11
DK0515415T3 (da) 1995-11-27
EP0515415A1 (de) 1992-12-02
ZA91947B (en) 1992-01-29
HK1004524A1 (en) 1998-11-27
ATE129159T1 (de) 1995-11-15
CA2075711A1 (en) 1991-08-13
PT96723B (pt) 1998-07-31
IE910424A1 (en) 1991-08-14
DE69113991T2 (de) 1996-03-21
NZ237069A (en) 1993-07-27
AU7211091A (en) 1991-09-03
EP0515415B1 (de) 1995-10-18
KR920703099A (ko) 1992-12-17
WO1991012020A1 (en) 1991-08-22
JP3035712B2 (ja) 2000-04-24
PT96723A (pt) 1991-10-31
KR100202052B1 (ko) 1999-06-15
AU646019B2 (en) 1994-02-03
ES2080941T3 (es) 1996-02-16
JPH05503936A (ja) 1993-06-24
CA2075711C (en) 2000-11-07
GR3018440T3 (en) 1996-03-31
DE69113991D1 (de) 1995-11-23

Similar Documents

Publication Publication Date Title
ATE127347T1 (de) Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
GR3018440T3 (en) Novel vaccine and method therefor.
FI860015L (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
AU8314587A (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
IL82825A0 (en) Preparation of toxoid
NO872919L (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
ES466359A1 (es) Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
YU41369B (en) Process for preparing benzofurnace derivatives
GR3019725T3 (en) Process
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
EP0338566A3 (en) Pertussis toxoid vaccine
NO981407L (no) Protein fra Helicobacter pylori
GR3017912T3 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same.
RO74766A2 (ro) Procedeu de preparare a unui vaccin destinat imunizarii cabalinelor contra rinopneumoniei